Literature DB >> 10501788

Altered calcium homeostasis in adults with cystic fibrosis.

R M Aris1, G E Lester, S Dingman, D A Ontjes.   

Abstract

Bone mineral density (BMD) in cystic fibrosis (CF) patients falls progressively below normal with advancing age, in part due to steroid administration, low levels of sex hormones, chronic inflammatory disease, physical inactivity, and chronic malabsorption of calcium and/or vitamin D. The purpose of this study was to compare the fractional absorption of (45)Ca and urinary excretion of calcium in CF subjects and normal controls following a high-calcium breakfast containing (45)Ca. Seven young men and 5 young women with CF with pancreatic insufficiency were studied on two separate occasions, with and without administration of pancreatic enzymes. Eleven healthy young adults with normal BMD measurements served as controls. Mean T-scores at the lumbar spine and femur were significantly lower in the CF subjects (p<0.002). Following baseline, fasting collections, timed serum and urine samples were obtained for 5 h after the meal. Fractional absorption (FA) of (45)Ca was estimated by the method of Marshall and Nordin. At baseline, CF subjects had lower mean serum 25-hydroxyvitamin D, calcium and albumin values (p<0.03 for each), slightly, but not significantly (p = 0.12), lower albumin-corrected calcium values, equivalent serum 1, 25-dihydroxyvitamin D values and a trend toward a higher mean serum parathyroid hormone (PTH) value (p = 0.10). Without pancreatic enzymes, CF subjects showed significantly impaired calcium absorption (5 h FA: 11.8 +/- 0.5 for controls vs 8.9 +/- 0.2 for CF subjects, p = 0.02) and excretion (4 h excretion: 0.20 +/- 0.08 mg Ca/mg creatinine for controls vs 0.16 +/- 0.09 mg Ca/mg for CF subjects, p = 0.025). Addition of pancreatic enzymes did not fully compensate for this deficiency. In addition, CF patients had higher serum PTH values after a high-calcium meal (p = 0.03), suggesting mild secondary hyperparathyroidism. Altered calcium homeostasis is likely to be a factor in the development of bone disease in CF patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501788     DOI: 10.1007/s001980050202

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  9 in total

Review 1.  Bone abnormalities in gastrointestinal and hepatic disease.

Authors:  F A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.

Authors:  Michael P Boyle; Michelle L Noschese; Sharon L Watts; Marsha E Davis; Shane E Stenner; Noah Lechtzin
Journal:  Am J Respir Crit Care Med       Date:  2005-04-28       Impact factor: 21.405

3.  Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis.

Authors:  H M Buntain; P J Schluter; S C Bell; R M Greer; J C H Wong; J Batch; P Lewindon; C E Wainwright
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

4.  Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls.

Authors:  Ristan M Greer; Helen M Buntain; Julia M Potter; Claire E Wainwright; Joseph C Wong; Peter K O'Rourke; Paul W Francis; Scott C Bell; Jennifer A Batch
Journal:  Osteoporos Int       Date:  2003-04-08       Impact factor: 4.507

Review 5.  Cystic fibrosis-related bone disease: insights into a growing problem.

Authors:  Michael S Stalvey; Gregory A Clines
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-12       Impact factor: 3.243

6.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

7.  A prospective study of change in bone mineral density over one year in adults with cystic fibrosis.

Authors:  C S Haworth; P L Selby; A W Horrocks; E B Mawer; J E Adams; A K Webb
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

8.  Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.

Authors:  S A Brown; D A Ontjes; G E Lester; R K Lark; M B Hensler; A D Blackwood; M J Caminiti; D C Backlund; R M Aris
Journal:  Osteoporos Int       Date:  2003-05-28       Impact factor: 4.507

Review 9.  Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis.

Authors:  Vittorio Ferrari; Vito Terlizzi; Stefano Stagi
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.